Ocrevus Subcutaneous: Valuing the benefits to people living with MS, whānau caregivers, and the health system
September 24, 2025
Ocrevus Subcutaneous (SC) is a new treatment for people with multiple sclerosis (MS), which is not funded by Pharmac. The key difference between Ocrevus SC and Ocrevus IV, which is funded by Pharmac, is that Ocrevus SC is delivered as an injection rather than by infusion. Clinically, … Read more
NZIER Consensus Forecasts point to a downward revision in the pace of economic recovery over the coming year
September 15, 2025
The latest NZIER Consensus Forecasts show a downward revision to the growth outlook for the year ending March 2026, relative to the previous release of Consensus Forecasts. Annual average GDP is forecast to increase by 1.5 percent in the year to March 2026 before growth picks up to 2. … Read more
